Emerald Health Therapeutics Inc

CVE:EMH ISIN:CA29102R1064

Emerald Health Therapeutics Inc (CVE:EMH), based in British Columbia and federally licensed under the Marihuana for Medical Purposes Regulations (MMPR), cultivates high-quality, regulated medical cannabis using proven and standardized growing methods while applying our research capabilities to discover potential medicinal benefits of cannabis for the future.

News

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Labs Enters Contract with Emerald (CVE:EMH)

🕔10/11/2018 10:13:59 AM 7813

MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) is pleased to attach a release from MediPharm Labs Inc (TSX-V: LABS) announcing that it has entered into a Cannabis Concentrate Program Agreement with Emerald Health Therapeutics Inc (CVE:EMH).

Read Full Article▸

MMJ PhytoTech Ltd (ASX:MMJ) Core Cannabis Brands to List on TSX-V via RTO

🕔9/28/2016 9:51:19 AM 10884

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that it is set to unlock significant value for shareholders through the spin out of its core cannabis subsidiaries, United Greeneries Holdings Ltd and Satipharm AG, on the TSX-V.